Cargando…
Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome
OBJECTIVE: Metabolic syndrome (MS) is defined by a cluster of interdependent physiological, biochemical, and clinical risk factors and linked to a state of chronic inflammation. YKL-40 is known as an inflammatory glycoprotein, which is secreted by various cell lines during inflammation. Thus, we aim...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324916/ https://www.ncbi.nlm.nih.gov/pubmed/27443476 http://dx.doi.org/10.14744/AnatolJCardiol.2016.6933 |
_version_ | 1782510287067283456 |
---|---|
author | Akboğa, Mehmet Kadri Yalçın, Rıdvan Şahinarslan, Asife Demirtaş, Canan Yılmaz Paşaoğlu, Hatice Abacı, Adnan |
author_facet | Akboğa, Mehmet Kadri Yalçın, Rıdvan Şahinarslan, Asife Demirtaş, Canan Yılmaz Paşaoğlu, Hatice Abacı, Adnan |
author_sort | Akboğa, Mehmet Kadri |
collection | PubMed |
description | OBJECTIVE: Metabolic syndrome (MS) is defined by a cluster of interdependent physiological, biochemical, and clinical risk factors and linked to a state of chronic inflammation. YKL-40 is known as an inflammatory glycoprotein, which is secreted by various cell lines during inflammation. Thus, we aimed to assess the association of serum YKL-40 levels with the presence and severity of MS. METHODS: In this prospective cross-sectional study, a total of 177 consecutive patients [n=114 MS present and n=63 MS absent] were enrolled. MS was defined according to National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria. Serum YKL-40 and hs-CRP levels were measured for all participants. RESULTS: Serum YKL-40, hs-CRP and white blood cell count (WBC) were significantly higher in the MS present group (p<0.05). There was a graded relationship between increasing number of MS components and serum YKL-40 level (p<0.05). In addition, serum YKL-40 level was positively correlated with hs-CRP level (r=0.467, p<0.001) and WBC count (r=0.251, p=0.001). In multivariable regression analysis, serum YKL-40 [1.022 (1.011–1.033), p<0.001] and hs-CRP [1.346 (1.111–1.632), p=0.002] were remained as independent predictors for the presence of MS. In the ROC curve analysis, using a cut-off level of 147.0, YKL-40 well predicted the presence of MS with a sensitivity of 73.7% and specificity of 69.8% (AUC: 0.785; 95% CI: 0.718–0.853, p<0.001). CONCLUSION: In this study, we demonstrated that serum YKL-40 level was significantly associated with the presence of MS. According to these findings, we concluded that serum YKL-40 may be a novel and useful indicator for MS. (Anatol J Cardiol 2016; 16: 953-8) |
format | Online Article Text |
id | pubmed-5324916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Kare Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-53249162017-06-28 Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome Akboğa, Mehmet Kadri Yalçın, Rıdvan Şahinarslan, Asife Demirtaş, Canan Yılmaz Paşaoğlu, Hatice Abacı, Adnan Anatol J Cardiol Original Investigation OBJECTIVE: Metabolic syndrome (MS) is defined by a cluster of interdependent physiological, biochemical, and clinical risk factors and linked to a state of chronic inflammation. YKL-40 is known as an inflammatory glycoprotein, which is secreted by various cell lines during inflammation. Thus, we aimed to assess the association of serum YKL-40 levels with the presence and severity of MS. METHODS: In this prospective cross-sectional study, a total of 177 consecutive patients [n=114 MS present and n=63 MS absent] were enrolled. MS was defined according to National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria. Serum YKL-40 and hs-CRP levels were measured for all participants. RESULTS: Serum YKL-40, hs-CRP and white blood cell count (WBC) were significantly higher in the MS present group (p<0.05). There was a graded relationship between increasing number of MS components and serum YKL-40 level (p<0.05). In addition, serum YKL-40 level was positively correlated with hs-CRP level (r=0.467, p<0.001) and WBC count (r=0.251, p=0.001). In multivariable regression analysis, serum YKL-40 [1.022 (1.011–1.033), p<0.001] and hs-CRP [1.346 (1.111–1.632), p=0.002] were remained as independent predictors for the presence of MS. In the ROC curve analysis, using a cut-off level of 147.0, YKL-40 well predicted the presence of MS with a sensitivity of 73.7% and specificity of 69.8% (AUC: 0.785; 95% CI: 0.718–0.853, p<0.001). CONCLUSION: In this study, we demonstrated that serum YKL-40 level was significantly associated with the presence of MS. According to these findings, we concluded that serum YKL-40 may be a novel and useful indicator for MS. (Anatol J Cardiol 2016; 16: 953-8) Kare Publishing 2016-12 2016-06-29 /pmc/articles/PMC5324916/ /pubmed/27443476 http://dx.doi.org/10.14744/AnatolJCardiol.2016.6933 Text en Copyright © 2016 Turkish Society of Cardiology http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Original Investigation Akboğa, Mehmet Kadri Yalçın, Rıdvan Şahinarslan, Asife Demirtaş, Canan Yılmaz Paşaoğlu, Hatice Abacı, Adnan Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome |
title | Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome |
title_full | Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome |
title_fullStr | Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome |
title_full_unstemmed | Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome |
title_short | Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome |
title_sort | increased serum ykl-40 level is associated with the presence and severity of metabolic syndrome |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324916/ https://www.ncbi.nlm.nih.gov/pubmed/27443476 http://dx.doi.org/10.14744/AnatolJCardiol.2016.6933 |
work_keys_str_mv | AT akbogamehmetkadri increasedserumykl40levelisassociatedwiththepresenceandseverityofmetabolicsyndrome AT yalcınrıdvan increasedserumykl40levelisassociatedwiththepresenceandseverityofmetabolicsyndrome AT sahinarslanasife increasedserumykl40levelisassociatedwiththepresenceandseverityofmetabolicsyndrome AT demirtascananyılmaz increasedserumykl40levelisassociatedwiththepresenceandseverityofmetabolicsyndrome AT pasaogluhatice increasedserumykl40levelisassociatedwiththepresenceandseverityofmetabolicsyndrome AT abacıadnan increasedserumykl40levelisassociatedwiththepresenceandseverityofmetabolicsyndrome |